EUZ.F Eckert & Ziegler Strahlen- und Medizintechnik AG

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
14.06 EUR
Close of Nov 11, 2026
12.01 16.53
Market cap
EUR 880M
P/E
17.6x
P/B
3.24x
ROE
16.6%
Dividend yield
1.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is EUZ.F undervalued?

Graham number
Price14.06
Graham value8.84
Premium59.1%

EUZ.F trades 59.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Eckert & Ziegler Strahlen- und Medizintechnik AG fundamental analysis

No fundamental analysis for Eckert & Ziegler Strahlen- und Medizintechnik AG yet.

Eckert & Ziegler Strahlen- und Medizintechnik AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therap…

Full company profile